Stimulation of accumbal GABAB receptors inhibits delta1-and delta2-opioid receptor-mediated dopamine efflux in the nucleus accumbens of freely moving rats

被引:9
|
作者
Watanabe, Yuriko [1 ,4 ]
Aono, Yuri [2 ]
Komiya, Masamichi [1 ]
Waddington, John L. [3 ]
Saigusa, Tadashi [2 ]
机构
[1] Nihon Univ, Sch Dent Matsudo, Dept Oral Surg, 2-870-1 Sakaecho Nishi, Matsudo, Chiba 2718587, Japan
[2] Nihon Univ, Sch Dent Matsudo, Dept Pharmacol, 2-870-1 Sakaecho Nishi, Matsudo, Chiba 2718587, Japan
[3] Royal Coll Surgeons Ireland, Mol & Cellular Therapeut, Dublin 2, Ireland
[4] Nihon Univ, Grad Sch Dent Matsudo, Oral Surg, 2-870-1 Salcaecho Nishi, Matsudo, Chiba 2718587, Japan
基金
爱尔兰科学基金会; 日本学术振兴会;
关键词
GABA(B) receptor; Delta1-opioid receptor; Delta2-opioid receptor; Nucleus accumbens; Dopamine; Microdialysis; OPIOID RECEPTORS; INDUCED INCREASES; RELEASE; MICRODIALYSIS; NEURONS; ACTIVATION; NEOSTRIATUM; DELTORPHIN; GLUTAMATE; SUBTYPES;
D O I
10.1016/j.ejphar.2018.08.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The nucleus accumbens contains delta-opioid receptors that may decrease inhibitory neurotransmission. As GABA(B) receptors inhibit dopamine release, decrease in activation of GABA(B) receptors may be a mediator of delta-opioid receptor-induced accumbal dopamine efflux. If so, accumbal dopamine efflux induced by delta-opioid receptor activation should be suppressed by stimulating GABA(B) receptors. As delta-opioid receptors are further subdivided into delta1- and delta2-opioid receptors, we analysed the effects of the GABA(B) receptor agonist baclofen on delta1- and delta2-opioid receptor-mediated accumbal dopamine efflux in freely moving rats using in vivo microdialysis. Drugs were applied intracerebrally through the dialysis probe. Doses of compounds show total amount administered (mol) during 25-50 min infusions. Baclofen (2.5 and 5.0 nmol), which did not alter basal dopamine levels, inhibited the delta1-opioid receptor agonist DPDPE (5.0 nmol)-induced dopamine efflux. Baclofen (2.5 and 5.0 nmol) also inhibited the delta2-opioid receptor agonist deltorphin II (25.0 nmol)-induced dopamine efflux. A low dose of the GABA(B) receptor antagonist 2-hydroxysaclofen (100.0 pmol), which failed to alter basal accumbal dopamine levels, counteracted the inhibitory effects of baclofen (5.0 nmol) on DPDPE (5.0 nmol)- and deltorphin II (25.0 nmol)-induced dopamine efflux. The present results show that reduction in accumbal GABA(B) receptor-mediated inhibition of accumbal dopaminergic activity facilitates activation of delta1- and delta2-opioid receptor-induced increases in accumbal dopamine efflux. This study suggests that activation of delta1- and delta2-opioid receptors on the cell bodies and/or terminals of accumbal GABAergic interneurons inhibits GABA release and, accordingly, decreases GABA(B) receptor-mediated inhibition of dopaminergic terminals, resulting in enhanced accumbal dopamine efflux.
引用
下载
收藏
页码:88 / 95
页数:8
相关论文
共 50 条